Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IPHC 2027

Bipolar Disorders at IPHC 2027

Part of the IPHC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Bipolar Disorders Session

A mental illness called bipolar disorder, formerly known as manic depression, is characterised by cycles of melancholy and excessively high mood that can last anywhere from days to weeks at a time. Mania is the name for an elevated mood that is extreme or linked to psychosis; hypomania is the name for one that is less severe. Mania is a condition in which a person exhibits unusually euphoric, cheerful, or irritated behaviour or feelings and frequently acts impulsively without carefully considering the implications. During manic episodes, the need for sleep is often decreased. The person may cry, have a pessimistic attitude on life, and make poor eye contact with others while depressed. There is a substantial risk of suicide; over a with bipolar illness committed themselves, while 30–40% hurt themselves. Bipolar disease is 20-year period, 6% of people frequently linked to other mental health conditions, such as anxiety disorders and substance use disorders. Although the exact origins of this mood illness are unknown, it is believed that both hereditary and environmental factors are involved. The condition may occur as a result of several genes, each of which has very minor impact. About 70–90% of the chance of having bipolar disorder is influenced by genetic factors. Long-term stress and a history of child abuse are environmental risk factors. If there has been at least one manic episode—with or without depressed episodes—the disease is categorised as bipolar I disorder, and as bipolar II disorder if there has been at least one hypomanic episode—but no complete manic episodes—and one major depressive episode. When hypomanic episodes coexist with depressive episodes that don't match the standards for severe depressive episodes, the condition is referred to as cyclothymia. Bipolar disorder is not diagnosed if these symptoms are brought on by medications or health issues. Attention deficit hyperactivity disorder, personality disorders, schizophrenia, substance use disorder, as well as many other medical conditions, are additional conditions that share symptoms with bipolar disorder.

Topics Covered in Bipolar Disorders

Topic 01

Manic, hypomanic and depressive episodes

Topic 02

Bipolar I, bipolar II and cyclothymia

Topic 03

Genetic and environmental risk factors

Topic 04

Suicide and self-harm risk in mood disorders

Topic 05

Differential diagnosis and comorbid conditions

Topic 06

Long-term treatment and relapse prevention

Featured Speakers — Bipolar Disorders 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Bipolar Disorders Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IPHC 2027

Why Attend the Bipolar Disorders Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Bipolar Disorders work, reviewed by the scientific committee.

Network Globally

Meet public health researchers, educators, and policy leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Bipolar Disorders research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IPHC 2027 for the Bipolar Disorders track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Bipolar Disorders Conference 2027 — FAQs

What is the Bipolar Disorders track at IPHC 2027?

The Bipolar Disorders track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Bipolar Disorders. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Bipolar Disorders sessions?

Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Bipolar Disorders are all welcome — whether presenting or attending.

Can I present my research in the Bipolar Disorders track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Bipolar Disorders sessions?

Yes. IPHC 2027 is a hybrid conference — attend the Bipolar Disorders track in person in Singapore or join live online, with on-demand access afterward.

Join the IPHC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us